International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts | Zendy

Christoph Thomssen | Zendy; Diana Lüftner | Zendy; Michael Untch | Zendy; Renate Haidinger | Zendy; Rachel Würstlein | Zendy; Nadia Harbeck | Zendy; Doris Augustin | Zendy; Susanne Briest | Zendy; Johannes Ettl | Zendy; Peter A. Fasching | Zendy; Frank Förster | Zendy; Christian M. Kurbacher | Zendy; HansJoachim Lück | Zendy; Norbert Marschner | Zendy; Lothar Müller | Zendy; Volkmar Müller | Zendy; Lidia Perlova-Griff | Zendy; I Radke | Zendy; Eugen Ruckhäberle | Zendy; Iris Scheffen | Zendy; Eva Schumacher-Wulf | Zendy; Moritz Schwoerer | Zendy; Dieter SteinfeldBirg | Zendy; Katja Ziegler-Löhr | Zendy

Open Access

International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus – Assessment by a German Group of Experts

Author(s) -

Christoph Thomssen,

Diana Lüftner,

Michael Untch,

Renate Haidinger,

Rachel Würstlein,

Nadia Harbeck,

Doris Augustin,

Susanne Briest,

Johannes Ettl,

Peter A. Fasching,

Frank Förster,

Christian M. Kurbacher,

HansJoachim Lück,

Norbert Marschner,

Lothar Müller,

Volkmar Müller,

Lidia Perlova-Griff,

I Radke,

Eugen Ruckhäberle,

Iris Scheffen,

Eva Schumacher-Wulf,

Moritz Schwoerer,

Dieter SteinfeldBirg,

Katja Ziegler-Löhr

Publication year - 2020

Publication title -

breast care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 30

eISSN - 1661-3805

pISSN - 1661-3791

DOI - 10.1159/000505957

Subject(s) - consensus conference , medicine , breast cancer , german , family medicine , gynecology , cancer , oncology , history , archaeology

The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in and .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research